Fusion Gene Studies
in Kim Lab

FusionBase FusionGDB FusionGDB2 FusionPDB FusionNeoAntigen FusionAI FusionNW FGviewer Publication Contact
FusionGDB Logo

Home

Download

Statistics

Examples

Help

Contact
Center for Computational Systems Medicine
leaf

Fusion Gene Summary

leaf

Fusion Gene ORF analysis

leaf

Fusion Genomic Features

leaf

Fusion Protein Features

leaf

Fusion Gene Sequence

leaf

Fusion Gene PPI analysis

leaf

Related Drugs

leaf

Related Diseases

Fusion gene:ACTG1-GNAS (FusionGDB2 ID:HG71TG2778)

Fusion Gene Summary for ACTG1-GNAS

check button Fusion gene summary
Fusion gene informationFusion gene name: ACTG1-GNAS
Fusion gene ID: hg71tg2778
HgeneTgene
Gene symbol

ACTG1

GNAS

Gene ID

71

2778

Gene nameactin gamma 1GNAS complex locus
SynonymsACT|ACTG|DFNA20|DFNA26|HEL-176AHO|C20orf45|GNAS1|GPSA|GSA|GSP|NESP|PITA3|POH|SCG6|SgVI
Cytomap('ACTG1')('GNAS')

17q25.3

20q13.32

Type of geneprotein-codingprotein-coding
Descriptionactin, cytoplasmic 2cytoskeletal gamma-actinepididymis luminal protein 176protein ALEXprotein GNASprotein SCG6 (secretogranin VI)G protein subunit alpha Sadenylate cyclase-stimulating G alpha proteinalternative gene product encoded by XL-exonextra large alphas proteinguanine nucleotide binding protein (G protein), alpha
Modification date2020032720200329
UniProtAcc

P63261

.
Ensembl transtripts involved in fusion geneENST00000331925, ENST00000573283, 
ENST00000575087, ENST00000575842, 
Fusion gene scores* DoF score51 X 36 X 13=23868111 X 41 X 18=81918
# samples 58111
** MAII scorelog2(58/23868*10)=-5.36288097153997
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0		log2(111/81918*10)=-6.20554891117303
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
Context

PubMed: ACTG1 [Title/Abstract] AND GNAS [Title/Abstract] AND fusion [Title/Abstract]

Most frequent breakpointACTG1(79479009)-GNAS(57485858), # samples:1
Anticipated loss of major functional domain due to fusion event.
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types
** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10)

check button Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez
PartnerGeneGO IDGO termPubMed ID


check button Fusion gene information
* All genome coordinats were lifted-over on hg19.
* Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser.
SourceDiseaseSampleHgeneHchrHbpHstrandTgeneTchrTbpTstrand


Top

Fusion Gene ORF analysis for ACTG1-GNAS

check button Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure.
* Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser.
ORFHenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrand

check buttonORFfinder result based on the fusion transcript sequence of in-frame fusion genes.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandSeq length
(transcript)		BP loci
(transcript)		Predicted start
(transcript)		Predicted stop
(transcript)		Seq length
(amino acids)

check buttonDeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandNo-coding scoreCoding score

Top

Fusion Genomic Features for ACTG1-GNAS


check buttonFusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints.
HgeneHchrHbpHstrandTgeneTchrTbpTstrand1-pp (fusion gene breakpoint)


Top

Fusion Protein Features for ACTG1-GNAS


check button Four levels of functional features of fusion genes
Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/:79479009/:57485858)
- FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels.
- How to search
1. Put your fusion gene symbol.
2. Press the tab key until there will be shown the breakpoint information filled.
4. Go down and press 'Search' tab twice.
4. Go down to have the hyperlink of the search result.
5. Click the hyperlink.
6. See the FGviewer result for your fusion gene.
FGviewer

check buttonMain function of each fusion partner protein. (from UniProt)
HgeneTgene
ACTG1

P63261

.
FUNCTION: Actins are highly conserved proteins that are involved in various types of cell motility and are ubiquitously expressed in all eukaryotic cells. {ECO:0000305|PubMed:29581253}.FUNCTION: Transcriptional activator which is required for calcium-dependent dendritic growth and branching in cortical neurons. Recruits CREB-binding protein (CREBBP) to nuclear bodies. Component of the CREST-BRG1 complex, a multiprotein complex that regulates promoter activation by orchestrating a calcium-dependent release of a repressor complex and a recruitment of an activator complex. In resting neurons, transcription of the c-FOS promoter is inhibited by BRG1-dependent recruitment of a phospho-RB1-HDAC1 repressor complex. Upon calcium influx, RB1 is dephosphorylated by calcineurin, which leads to release of the repressor complex. At the same time, there is increased recruitment of CREBBP to the promoter by a CREST-dependent mechanism, which leads to transcriptional activation. The CREST-BRG1 complex also binds to the NR2B promoter, and activity-dependent induction of NR2B expression involves a release of HDAC1 and recruitment of CREBBP (By similarity). {ECO:0000250}.

check buttonRetention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at

download page


* Minus value of BPloci means that the break pointn is located before the CDS.
- In-frame and retained protein feature among the 13 regional features.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenProtein featureProtein feature note

- In-frame and not-retained protein feature among the 13 regional features.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenProtein featureProtein feature note


Top

Fusion Gene Sequence for ACTG1-GNAS


check button For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones.

Top

Fusion Gene PPI Analysis for ACTG1-GNAS


check button Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in

ChiPPI page.


check button Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160)
HgeneHgene's interactorsTgeneTgene's interactors


check button - Retained PPIs in in-frame fusion.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenStill interaction with


check button - Lost PPIs in in-frame fusion.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenInteraction lost with


check button - Retained PPIs, but lost function due to frame-shift fusion.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenInteraction lost with


Top

Related Drugs for ACTG1-GNAS


check button Drugs targeting genes involved in this fusion gene.
(DrugBank Version 5.1.8 2021-05-08)
PartnerGeneUniProtAccDrugBank IDDrug nameDrug activityDrug typeDrug status
HgeneACTG1P63261DB09130CopperSmall moleculeApproved|Investigational
HgeneACTG1P63261DB09130CopperSmall moleculeApproved|Investigational

Top

Related Diseases for ACTG1-GNAS


check button Diseases associated with fusion partners.
(DisGeNet 4.0)
PartnerGeneDisease IDDisease name# pubmedsSource
HgeneACTG1C3711374Nonsyndromic Deafness18CLINGEN
HgeneACTG1C1858172Deafness, Autosomal Dominant 208CTD_human;GENOMICS_ENGLAND;UNIPROT
HgeneACTG1C3281235BARAITSER-WINTER SYNDROME 24CLINGEN;CTD_human;GENOMICS_ENGLAND;UNIPROT
HgeneACTG1C0001787Osteoporosis, Age-Related1CTD_human
HgeneACTG1C0005745Blepharoptosis1GENOMICS_ENGLAND
HgeneACTG1C0007097Carcinoma1CTD_human
HgeneACTG1C0007621Neoplastic Cell Transformation1CTD_human
HgeneACTG1C0009363Congenital ocular coloboma (disorder)1CTD_human
HgeneACTG1C0014544Epilepsy1GENOMICS_ENGLAND
HgeneACTG1C0024433Macrostomia1GENOMICS_ENGLAND
HgeneACTG1C0024667Animal Mammary Neoplasms1CTD_human
HgeneACTG1C0024668Mammary Neoplasms, Experimental1CTD_human
HgeneACTG1C0029456Osteoporosis1CTD_human
HgeneACTG1C0029459Osteoporosis, Senile1CTD_human
HgeneACTG1C0033377Ptosis1GENOMICS_ENGLAND
HgeneACTG1C0205696Anaplastic carcinoma1CTD_human
HgeneACTG1C0205697Carcinoma, Spindle-Cell1CTD_human
HgeneACTG1C0205698Undifferentiated carcinoma1CTD_human
HgeneACTG1C0205699Carcinomatosis1CTD_human
HgeneACTG1C0240583Short upturned nose1GENOMICS_ENGLAND
HgeneACTG1C0265541Cranioschisis1CTD_human
HgeneACTG1C0266551Congenital coloboma of iris1ORPHANET
HgeneACTG1C0376634Craniofacial Abnormalities1CTD_human
HgeneACTG1C0497552Congenital neurologic anomalies1CTD_human
HgeneACTG1C0751406Post-Traumatic Osteoporosis1CTD_human
HgeneACTG1C0857379Abnormality of the pinna1GENOMICS_ENGLAND
HgeneACTG1C0948089Acute Coronary Syndrome1CTD_human
HgeneACTG1C1257925Mammary Carcinoma, Animal1CTD_human
HgeneACTG1C1384666hearing impairment1GENOMICS_ENGLAND
HgeneACTG1C1843156Progressive sensorineural hearing impairment1GENOMICS_ENGLAND
HgeneACTG1C1844505Pointed chin1GENOMICS_ENGLAND
HgeneACTG1C1849340Long palpebral fissure1GENOMICS_ENGLAND
HgeneACTG1C1855722Iris Coloboma with Ptosis, Hypertelorism, and Mental Retardation1ORPHANET
HgeneACTG1C1865014Long philtrum1GENOMICS_ENGLAND
HgeneACTG1C1865017Thin upper lip vermilion1GENOMICS_ENGLAND
HgeneACTG1C1868571Highly arched eyebrow1GENOMICS_ENGLAND
HgeneACTG1C1970280Hearing loss begins with loss of high frequencies1GENOMICS_ENGLAND
HgeneACTG1C1970281Audiogram shows sloping configuration1GENOMICS_ENGLAND
HgeneACTG1C1970282Deafness, profound, by 6th decade1GENOMICS_ENGLAND
HgeneACTG1C3279369Microphthalmia (in some patients)1GENOMICS_ENGLAND
HgeneACTG1C3549665Deafness (in some patients)1GENOMICS_ENGLAND
HgeneACTG1C3808883Short neck (in some patients)1GENOMICS_ENGLAND
HgeneACTG1C4012410Enlarged ventricles (in some patients)1GENOMICS_ENGLAND
HgeneACTG1C4229649Heart defect (in some patients)1GENOMICS_ENGLAND
HgeneACTG1C4229650Pterygium colli (in some patients)1GENOMICS_ENGLAND
HgeneACTG1C4229651Hypertelorism/telecanthus1GENOMICS_ENGLAND
HgeneACTG1C4229652Eye coloboma (in some patients)1GENOMICS_ENGLAND
HgeneACTG1C4229653Trigonocephaly/metopic ridge1GENOMICS_ENGLAND
HgeneACTG1C4231117Pectus (in some patients)1GENOMICS_ENGLAND
HgeneACTG1C4231118Kyphosis/scoliosis (in some patients)1GENOMICS_ENGLAND
HgeneACTG1C4231120Prominent nasal root on profile1GENOMICS_ENGLAND
HgeneACTG1C4231121Large, squared nose tip1GENOMICS_ENGLAND
HgeneACTG1C4231123Retrognathia (in some patients)1GENOMICS_ENGLAND
HgeneACTG1C4231124Prominent/full/wide cheeks1GENOMICS_ENGLAND
HgeneACTG1C4554007Uveoretinal Coloboma1CTD_human
HgeneACTG1C4708599Coloboma of choroid and retina1ORPHANET
TgeneC3494506Pseudohypoparathyroidism, Type Ia17CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
TgeneC0242292McCune-Albright Syndrome7CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
TgeneC0016065Polyostotic fibrous dysplasia5CTD_human;ORPHANET
TgeneC1864100PSEUDOHYPOPARATHYROIDISM, TYPE IB5CTD_human;GENOMICS_ENGLAND;ORPHANET
TgeneC2931404Albright's hereditary osteodystrophy4CTD_human;GENOMICS_ENGLAND
TgeneC0033806Pseudohypoparathyroidism3CTD_human
TgeneC0334041Osteoma cutis3CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
TgeneC0014130Endocrine System Diseases2CTD_human
TgeneC0016064Fibrous Dysplasia, Monostotic2ORPHANET
TgeneC0034013Precocious Puberty2CTD_human
TgeneC0221263Cafe-au-Lait Spots2CTD_human
TgeneC0271527Cryptogenic sexual precocity2CTD_human
TgeneC0342543Central Precocious Puberty2CTD_human
TgeneC1504412Testotoxicosis2CTD_human
TgeneC1857451Acth-Independent Macronodular Adrenal Hyperplasia2CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
TgeneC2932716Pseudohypoparathyroidism Type 1C2GENOMICS_ENGLAND;ORPHANET;UNIPROT
TgeneC0001206Acromegaly1CTD_human
TgeneC0001624Adrenal Gland Neoplasms1CTD_human
TgeneC0003129Anoxemia1CTD_human
TgeneC0003130Anoxia1CTD_human
TgeneC0008370Cholestasis1GENOMICS_ENGLAND
TgeneC0009438Common Bile Duct Calculi1CTD_human
TgeneC0011573Endogenous depression1PSYGENET
TgeneC0019087Hemorrhagic Disorders1CTD_human
TgeneC0020538Hypertensive disease1CTD_human
TgeneC0020796Profound Mental Retardation1CTD_human
TgeneC0021655Insulin Resistance1CTD_human
TgeneC0023897Liver Diseases, Parasitic1CTD_human
TgeneC0025363Mental Retardation, Psychosocial1CTD_human
TgeneC0027819Neuroblastoma1CTD_human
TgeneC0028754Obesity1CTD_human
TgeneC0029396Heterotopic Ossification1CTD_human
TgeneC0032460Polycystic Ovary Syndrome1CTD_human
TgeneC0033835Pseudopseudohypoparathyroidism1CTD_human;GENOMICS_ENGLAND;ORPHANET
TgeneC0035204Respiration Disorders1CTD_human
TgeneC0036341Schizophrenia1PSYGENET
TgeneC0038587Substance Withdrawal Syndrome1CTD_human
TgeneC0039231Tachycardia1CTD_human
TgeneC0080203Tachyarrhythmia1CTD_human
TgeneC0086189Drug Withdrawal Symptoms1CTD_human
TgeneC0087169Withdrawal Symptoms1CTD_human
TgeneC0206698Cholangiocarcinoma1CTD_human
TgeneC0221357Brachydactyly1CTD_human
TgeneC0242184Hypoxia1CTD_human
TgeneC0242216Biliary calculi1CTD_human
TgeneC0345905Intrahepatic Cholangiocarcinoma1CTD_human
TgeneC0346302Growth Hormone-Secreting Pituitary Adenoma1CTD_human
TgeneC0700292Hypoxemia1CTD_human
TgeneC0750887Adrenal Cancer1CTD_human
TgeneC0917816Mental deficiency1CTD_human
TgeneC0920563Insulin Sensitivity1CTD_human
TgeneC1136382Sclerocystic Ovaries1CTD_human
TgeneC2932715Pseudohypoparathyroidism Type 1B1CTD_human;GENOMICS_ENGLAND;ORPHANET
TgeneC3489630Somatotrophinoma, Familial1CTD_human
TgeneC3697137Fibrous dysplasia of bone with intramuscular myxoma1ORPHANET
TgeneC3714756Intellectual Disability1CTD_human
TgeneC3805278Extrahepatic Cholangiocarcinoma1CTD_human